Androgenetic Alopecia as a Marker of Metabolic Syndrome
June 2021
in “
Journal of pharmaceutical research international
”
Studysummary This study found that metabolic syndrome was present in 10.1% of adult male patients with androgenetic alopecia, with higher prevalence in those over 40 and from lower socioeconomic backgrounds.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on journaljpri.com →